CDXC - MCAP CO - ChromaDex Corporation

ChromaDex Corporation (CDXC) focuses on scientific research in the field of longevity, promoting Tru Niagen through global distribution networks by 2026. The market trend visualized in monetary format on GURU.Markets, where the indicator stands at , helps track business dynamics. The company's revenues are based on integrating patented components into the formulations of well-known dietary supplements, while growth is driven by technology licensing without retail expenditures.

Investors utilize market capitalization as the primary indicator of a business's total value in the eyes of the exchange. This metric is calculated by multiplying the current share price by the total number of outstanding securities. By analyzing the capitalization dynamics of the issuer, one can determine the current value of . The growth in the valuation of ChromaDex Corporation (CDXC) confirms the effectiveness of scaling its global e-commerce network. The optimization of logistics hubs reduces costs, directly impacting the company's investment attractiveness.